MARGARET KRANZ: Open Payments
NPI 1033792536 · SUNNYSIDE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $84 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| ALK-Abello, Inc | 1 | $43 |
| Dexcom, Inc. | 1 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Sage Therapeutics, LLC | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $20 |
| Seqirus USA Inc | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: Grastek, Dexcom G6 Transmitter, Qelbree, ZURZUVAE, FLUZONE HIGH-DOSE, Fluad, QULIPTA, FARXIGA.
Industry payments across WA — which companies pay providers there.
